IL33 and influenza: Conversely, blocking the IL-33/IL-33R signaling pathway or the use of anti-CD90 monoclonal antibodies to block ILC2 expansion protected mice from the influenza-induced AHR, thereby proving an essential role of ILC2s in mediating airway inflammation (25).